A phase Ib study of IN10018 in combination with pegylated liposomal doxorubicin (PLD) in patients with platinum-resistant ovarian cancer.
JOURNAL OF CLINICAL ONCOLOGY（2022）
关键词
liposomal doxorubicin,ovarian cancer,in10018,platinum-resistant
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要